总时间（秒）：36.42
问答时间（秒）：34.77

<think>
Okay, let's start by reading through the provided literature carefully. The user wants me to extract variant information, disease terms, and experimental methods in a structured JSON format.

First, the variants. The main gene mentioned is DJ1, with a mutation c.192G>C (p.E64D). The literature also mentions another mutation, L166P, which is part of the PARK7 gene. I need to standardize the HGVS nomenclature. The original HGVS is c.192G>C, so I'll check if that's correct. The transcript is NM_001030091.2 (DJ1), so the HGVS would be NM_001030091.2:c.192G>C. The protein change is E64D. The description in the context is about the mutation in a Turkish patient and its functional significance, including reduced DAT binding.

Next, the disease. The study is about early-onset Parkinson disease (EOPD), which is associated with mutations in the DJ1 gene. The MONDO term for Parkinson disease is MONDO:0001660. The literature mentions autosomal recessive inherited PD, so that's the disease.

For the experimental methods: The study used crystallography to check the structure of DJ1, and immunocytochemistry to observe the localization. Also, they used [18F]FP-CIT and PET for dopamine uptake. There's also mention of HEK293 and COS7 cells. 

The readout types include PET scans (quantitative), immunocytochemistry (qualitative), and crystallography (qualitative). The results for the E64D variant show decreased protein levels when overexpressed and nuclear localization. The L166P variant is mentioned in the context of immunocytochemistry as well. 

For the experimental methods, the HEK293 cells are used for overexpression, and the [18F]FP-CIT is a PET scan. The crystallography is used to check the structure. The immunocytochemistry is done on cells expressing the variants. 

The controls: The study mentions a clinically unaffected brother as a control for the E64D mutation. The wild-type DJ1 is used as a positive control in HEK293 cells. The negative control might be the empty vector, but the text doesn't explicitly state that. 

Statistical analysis methods aren't mentioned in the literature, so I'll note that as N.D. The thresholds for normal and abnormal results are not provided in the text, so I'll use "N.D." for those. 

The approved assay for the methods: PET scans are commonly used in PD studies, so that's Yes. Immunocytochemistry is a standard method, so Yes. Crystallography is also a standard method, so Yes. But the HEK293 cell experiments might be considered as standard, so Yes. 

I need to make sure all these points are included in the JSON structure, using the correct fields and formatting. Also, check if there are any other variants or methods. The L166P is another variant, but the user's example only includes the E64D, but the literature mentions both. Wait, the literature says "a third mutation, c.192G>C (p.E64D), associated with EOPD... and characterized the functional significance of this amino acid substitution." Also, the L166P is mentioned as a recently described mutation. So the variants include both E64D and L166P. 

So the Variants Include should have both. The L166P is part of the DJ1 gene as well. Need to check the HGVS for that. The literature says "L166P" is a recently described mutation, but the HGVS isn't specified. However, the user's example includes the L166P in the readout description. So I need to include both variants. 

Wait, the user's example in the prompt includes a single variant, but the literature here has two. So I need to include both. The original HGVS for L166P is not given, but the text says "L166P" as a mutation. So maybe the HGVS is NM_001030091.2:c.599G>A? Wait, no, the user's example is just an example. The actual HGVS for L166P might be different, but since it's not provided, I have to use the given information. However, the literature mentions "L166P" as a mutation but doesn't give the HGVS. So maybe the HGVS is not available, but the user's example uses the HGVS. But in the literature, the only HGVS given is for E64D. So maybe only E64D is included, and L166P is just a protein change. But the user's example includes the protein change. So perhaps the user wants both variants. But the literature says "a third mutation, c.192G>C (p.E64D), associated with EOPD... and characterized the functional significance of this amino acid substitution." So the L166P is a different mutation, but the text doesn't provide HGVS for it. Therefore, maybe the user only wants the E64D variant. But the example in the prompt includes a single variant, so maybe I should only include E64D. Wait, the user's example is just an example. The actual answer should include all variants mentioned in the literature. The literature mentions both E64D and L166P as mutations. So I need to include both. However, the HGVS for L166P is not provided. So maybe the user expects that. But in the example, the HGVS is given. So perhaps I should include both, even if the HGVS is not provided. Wait, the user's instruction says to extract all relevant variant information, including HGVS. So if the literature doesn't specify, maybe I can't include it. But the example includes a HGVS, so maybe the user expects that. But in the literature, the only HGVS given is for E64D. The L166P is mentioned as a mutation but without HGVS. So perhaps I should only include E64D. But the example includes a variant with HGVS. So maybe the user wants only the E64D. Alternatively, maybe the L166P is a different mutation, but the text says "a third mutation, c.192G>C (p.E64D), associated with EOPD... and characterized the functional significance of this amino acid substitution." So the L166P is another mutation, but the text doesn't provide HGVS. Therefore, perhaps the answer should include E64D and mention L166P as a variant, but since HGVS is not given, maybe only E64D is included. But the example in the prompt includes a single variant. So maybe the answer should include E64D only. 

Wait, the user's example includes a single variant, but the literature here has two. However, the user's answer example is just an example. So perhaps in the actual answer, I need to include both variants, even if the HGVS is not given for L166P. But the user's instruction says to extract all relevant variant information. So if the HGVS is not given, maybe it's not included. But the literature says "L166P" is a mutation, so maybe the HGVS is not available. Therefore, the answer should include E64D, and maybe L166P as a protein change. But the HGVS is not given. However, the user's example includes a HGVS. So perhaps the answer should only include E64D. 

Alternatively, maybe the L166P is part of the same gene, DJ1, and the HGVS is not provided, so I can't include it. Therefore, the answer should focus on E64D. 

So, the final answer includes the E64D variant with the HGVS, and the disease is Parkinson disease with MONDO:0001660. The experimental methods include crystallography, immunocytochemistry, and PET scans. The readout descriptions for the E64D variant include decreased protein levels and nuclear localization. The L166P is not included because its HGVS is not given. 

Now, structuring the JSON accordingly. Make sure that the HGVS is standardized. For E64D, the transcript is NM_001030091.2 (DJ1), position 192. The HGVS is NM_001030091.2:c.192G>C. 

The disease is Parkinson disease, MONDO:0001660. 

The experimental methods: 

1. Crystallography: to check the structure. 
2. Immunocytochemistry: to observe localization. 
3. PET scan with [18F]FP-CIT: to measure dopamine uptake. 

Each method has its own details. 

For the PET scan, the readout is quantitative. The immunocytochemistry is qualitative. Crystallography is qualitative. 

The results for E64D: decreased protein levels when overexpressed and nuclear localization. 

The controls: the clinically unaffected brother is a control for the E64D mutation. The wild-type DJ1 is used as a positive control in HEK293 cells. 

Statistical analysis methods: not mentioned, so N.D. 

Thresholds: not specified, so N.D. 

Approved assays: PET is approved, immunocytochemistry is standard, crystallography is standard. 

So, the final JSON should include all these points.
</think>

{
  "Variants Include": [
    {
      "Gene": "DJ1",
      "variants": [
        {
          "HGVS": "NM_001030091.2:c.192G>C",
          "cDNA Change": {
            "transcript": "NM_001030091.2",
            "ref": "G",
            "alt": "C",
            "position": "192"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          },
          "Description in input context": "This mutation is associated with early-onset Parkinson disease and is characterized by reduced dopamine transporter (DAT) binding and nuclear localization of the protein."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Early-onset Parkinson disease",
    "MONDO": "MONDO:0001660"
  },
  "Experiment Method": [
    {
      "Assay Method": "Crystallography",
      "Material used": {
        "Material Source": "Protein",
        "Material Name": "DJ1",
        "Description": "Crystal structures of DJ1 were determined to assess structural changes in the protein."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001030091.2:c.192G>C",
          "Conclusion": "Normal structure",
          "Molecular Effect": "No structural change",
          "Result Description": "The crystal structure of DJ1 with the c.192G>C mutation showed no significant conformational changes."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunocytochemistry",
      "Material used": {
        "Material Source": "Cell lines",
        "Material Name": "DJ1",
        "Description": "Immunocytochemical analysis of DJ1 expression and localization in cultured cells."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001030091.2:c.192G>C",
          "Conclusion": "Altered localization",
          "Molecular Effect": "Nuclear accumulation",
          "Result Description": "The c.192G>C mutation caused abnormal nuclear localization of DJ1 in cultured cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/L:
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "PET/CT",
      "Material used": {
        "Material Source": "Animal models",
        "Material Name": "Dopamine transporter",
        "Description": "PET imaging with [18F]FP-CIT to assess dopamine transporter function in affected individuals."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001030091.2:c.192G>C",
          "Conclusion": "Reduced binding",
          "Molecular Effect": "Altered DAT function",
          "Result Description": "The c.192G>C mutation was associated with decreased [18F]FP-CIT binding in affected individuals."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}